Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
23-Jul-2021
2021 Corporate Governance Statement
23-Jul-2021
Annual Report to Shareholders - YE 31 March 2021
23-Jul-2021
Notice of Annual General Meeting/Proxy Form
21-Jul-2021
Results from Successful Phase 1 Clinical Trial of AMP945
29-Jun-2021
Financial Report YE 31 March 2021 - Audited
28-Jun-2021
Amplia and Garvan Enter Into Collaboration Agreement
25-Jun-2021
Annual General Meeting to be Held 27 August 2021
8-Jun-2021
Change of Director's Interest - Dr. Lambert Exercise Options
7-Jun-2021
Application for quotation of securities - ATX
7-Jun-2021
Application for quotation of securities - ATX
Previous
1
2
3
4
5
6
7
8
9
Next